Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Pfizer’s Xeljanz becomes first JAK inhibitor approved in US for active ulcerative colitis

May 31, 2018
Sales and Marketing FDA, Pfizer, US, Xeljanz, pharma, ulcerative colitis

Pfizer has revealed that its Janus kinase (JAK) inhibitor Xeljanz (tofacitinib) has received FDA approval for the treatment of adult …

News

Pfizer’s Lyrica achieves endpoint as adjunct in paediatric epilepsy

May 18, 2018
Medical Communications, Research and Development FDA, Lyrica, Pfizer, epilepsy, pharma

Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …

News

Pfizer scores approval for first Epogen/Procrit biosimilar in the US

May 16, 2018
Research and Development, Sales and Marketing Epogen, Pfizer, Procrit, Retacrit, biosimilar, pharma FDA

Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the …

News
merck_kgaa_pyramid_use_with_credit

Merck KGaA finds consumer health buyer in P&G for €3.4bn

April 19, 2018
Sales and Marketing Merck KGaA, P&G, Pfizer, biotech, drugs, pharma, pharmaceutical

Merck KGaA has successfully found a buyer for its healthcare unit, after Proctor & Gamble announced that it was prepared …

News
epi-pen_1_3

EpiPen shortage hits UK and Canada hard, but not US

April 18, 2018
Research and Development, Sales and Marketing Mylan, Pfizer, biotech, drugs, epipen, pharma, pharmaceutical

Manufacturing issues at the single Pfizer plant that produces the EpiPen epinephrine injector has caused serious shortages in the UK …

News
pfizer_hq_dark

Pfizer shuts down kidney cancer drug trial due to “futility”

April 11, 2018
Research and Development Cancer, Kidney cancer, Pfizer, inlyta, pharma

Pfizer has revealed that it has shut down a trial of its vascular endothelial growth factor (VEGF) inhibitor Inlyta (axitinib) …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

April 6, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Boehringer Ingelheim, Kite, Nordic Nanovector, Pfizer, Roche, Sanofi, biotech, cystic fibrosis, drugs, pharma, pharmaceutical

Some of the biggest news this week concerns companies that are looking to move on parts of their business, but …

News
pfizer_chrome_plate

Pfizer running out of options for consumer business

April 4, 2018
Research and Development, Sales and Marketing P&G, Pfizer, Procter & Gamble, biotech, drugs, pharma, pharmaceutical

A surprise new name was thrown into the ring to take on Pfizer’s healthcare unit but speculation suggests that valuation …

News
shaking-hands-3091908_960_720

Ex-Kite execs form a CAR T rival

April 4, 2018
Research and Development, Sales and Marketing Allogene, Pfizer, biotech, drugs, pharma, pharmaceutical

After working to bring through Kite Pharma from the pre-clinical development stage to its final $12 billion acquisition by Gilead, …

News
shutterstock_168864905

InSight Innovations to buy CureTech in $550m deal

March 28, 2018
Research and Development, Sales and Marketing Cancer, CureTech, Insight Innovations, Pfizer, Teva, brain cancer, brain tumour, immunotherapy, israel

Israeli drug firm CureTech is be sold for the third time in four years, this time to InSight Innovations in …

News

Pfizer seeks tax breaks in return for planned $456m facility

March 28, 2018
Manufacturing and Production, Research and Development Michigan, Pfizer, biotech, drugs, pharma, pharmaceutical, tax break

Pfizer has submitted proposals to officials in Portage, Michigan, for a major expansion of its manufacturing site in the city. …

News
gsk_boronia_australia

GSK withdraws from running for Pfizer Consumer Health

March 23, 2018
Medical Communications, Sales and Marketing GSK, Pfizer, Pfizer Consumer Health, biotech, drugs, pharma, pharmaceutical

GSK has announced that it has decided to pull out of the race to acquire Pfizer’s Consumer Health business, ending …

News

Pfizer to hang onto CEO, after 61% pay increase

March 19, 2018
Medical Communications, Sales and Marketing Ian Read, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer have given its Chief Executive Officer, Ian Read, a big boost to his pay packet, taking it to $27.9 …

News
biology-think-networking-physiology-brain-anatomy-2676370

Pfizer begins sell-off, shedding CNS drug to Biogen for $590m

March 13, 2018
Manufacturing and Production, Sales and Marketing Biogen, CNS, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer’s decision to back out of the neuroscience space was a strategic move that send shudders through the entire industry, …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026